GlassScriptPhysician profile
Julius Arash Danesh
NPI 1740683119
$2,575.22
in general payments reported to CMS, 2019-2025
9 companies · $295 in 2025
The $295 reported for 2025 was less than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $151 · 2021: $142 · 2022: $67.98 · 2023: $1,657 · 2024: $262 · 2025: $295.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,382 · Travel and Lodging: $831.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,382.48 |
| Travel and Lodging | $831.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,332.64 | 2023-2025 | Intellis Adaptivestim, Vectris Surescan, Vanta Adaptivestim |
| Stryker Corporation | $419.88 | 2023 | Spinejack |
| Spr Therapeutics, INC | $206.53 | 2022-2023 | Sprint Pns System |
| Nevro Corp. | $179.11 | 2023 | Senza |
| Medtronic USA, INC. | $151.13 | 2020 | |
| Abbott Laboratories | $142.43 | 2021 | |
| Tonix Medicines, INC. | $77.10 | 2025 | |
| Si-Bone, INC. | $48.88 | 2025 | |
| Avanos Medical | $17.52 | 2024 | Coolief* Cooled Radiofrequency |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julius Danesh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.